The first clinical trial for a new COVID-19 vaccine developed by a U.S. biotech firm will begin in April at NIAID’s clinical-trials unit in Bethesda

n Monday, when China reported 409 new cases of COVID-19 infection and 150 more deaths, Massachusetts-based biotechnology company Moderna, Inc. delivered the first batch of its rapidly developed coronavirus vaccine to the U.S. National Institutes of Health (NIH). As of early Tuesday afternoon, Hong Kong time, there are 80,147 confirmed cases of COVID-19 and 2,699 deaths. In

Read More


News about Vaccine Technologies Deployed to Develop COVID-19 Shot

Researchers look to messenger RNA encased in nanoparticles, DNA plasmids, molecular clamps and other approaches as they rush to design a vaccine against the new coronavirus. The Chinese Center for Disease Control and Prevention reported on February 20 that the novel coronavirus illness known as COVID-19 has now infected nearly 75,000 people and that the number of fatalities in

Read More


Tackling the Challenges in Cell and Gene Therapy Manufacturing

The excitement about cell and gene therapies is almost tangible within the biotech and pharma industry. Over 950 companies are actively developing advanced therapies, which are expected to make exceptional improvements to peoples’ lives in the next decade. Although hopes are high, the industry still faces a number of challenges in cell and gene therapy manufacturing, mainly

Read More


Report claims two-thirds of global coronavirus cases have gone undetected

A new report from a WHO infectious disease modeling team based at Imperial College London is estimating about two-thirds of Covid-19 cases worldwide have gone undetected. The analysis suggests the global spread of the novel coronavirus is significantly greater than the current volume of confirmed cases. Source: Imperial College London “We are starting to see more

Read More


Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes

Immunotherapy has unleashed a revolution in care for some cancer patients. But most immunotherapies help only a small subset of patients, meaning doctors often have to resort to a trial-and-error process to determine who might actually benefit from the novel treatments. Now, scientists have developed a new metric they believe can help predict whether patients will respond

Read More


Covid-19 incubation could be as long as 27 days, Chinese provincial government says

Source Reuters A 70-year-old man in China’s Hubei Province was infected with coronavirus but did not show symptoms until 27 days later, the local government said on Saturday, meaning the virus’ incubation period could be much longer than the presumed 14 days. A longer incubation period could complicate efforts to contain spread of the epidemic

Read More